Forglyn Respicap is used for the long-term management of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). It contains formoterol fumarate and glycopyrronium, two long-acting bronchodilators.
Formoterol and glycopyrronium both relax the muscles around the airways, but through different mechanisms, opening the airways and reducing breathlessness, which together improve airflow and reduce COPD symptoms with regular use.
Use this respicap only with the appropriate inhaler device, as your doctor prescribes, usually once or twice daily, and the capsule is for inhalation only and must not be swallowed.
Do not stop this medicine on your own, even if you feel well, as it works to control symptoms over time. Tell your doctor about any heart conditions, glaucoma or difficulty passing urine before starting, and keep a short-acting reliever inhaler available for sudden symptoms.










































































